These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 33142052)

  • 1. The effect of emerging molecular and genetic therapies on cardiopulmonary disease in Duchenne muscular dystrophy.
    McKim DA; Cripe TP; Cripe LH
    Pediatr Pulmonol; 2021 Apr; 56(4):729-737. PubMed ID: 33142052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac Pathophysiology and the Future of Cardiac Therapies in Duchenne Muscular Dystrophy.
    Meyers TA; Townsend D
    Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31443395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiomyopathy of Duchenne muscular dystrophy: current understanding and future directions.
    Spurney CF
    Muscle Nerve; 2011 Jul; 44(1):8-19. PubMed ID: 21674516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiomyopathy in Duchenne muscular dystrophy: pathogenesis and therapeutics.
    Fayssoil A; Nardi O; Orlikowski D; Annane D
    Heart Fail Rev; 2010 Jan; 15(1):103-7. PubMed ID: 19943106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New approaches in the therapy of cardiomyopathy in muscular dystrophy.
    McNally EM
    Annu Rev Med; 2007; 58():75-88. PubMed ID: 17217326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in the diagnosis and management of cardiomyopathy in Duchenne muscular dystrophy.
    Hor KN; Mah ML; Johnston P; Cripe TP; Cripe LH
    Neuromuscul Disord; 2018 Sep; 28(9):711-716. PubMed ID: 30064893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is there a future for the use of left ventricular assist devices in Duchenne muscular dystrophy?
    Hayes EA; Nandi D
    Pediatr Pulmonol; 2021 Apr; 56(4):753-759. PubMed ID: 33245216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dystrophin-Deficient Cardiomyopathy.
    Kamdar F; Garry DJ
    J Am Coll Cardiol; 2016 May; 67(21):2533-46. PubMed ID: 27230049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel mouse model of Duchenne muscular dystrophy carrying a multi-exonic
    Wong TWY; Ahmed A; Yang G; Maino E; Steiman S; Hyatt E; Chan P; Lindsay K; Wong N; Golebiowski D; Schneider J; Delgado-Olguín P; Ivakine EA; Cohn RD
    Dis Model Mech; 2020 Sep; 13(9):. PubMed ID: 32988972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic Approaches for Duchenne Muscular Dystrophy: Old and New.
    Mackenzie SJ; Nicolau S; Connolly AM; Mendell JR
    Semin Pediatr Neurol; 2021 Apr; 37():100877. PubMed ID: 33892842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Manifestations and Overall Management Strategies for Duchenne Muscular Dystrophy.
    Tsuda T
    Methods Mol Biol; 2018; 1687():19-28. PubMed ID: 29067653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Draft Guidance for Industry Duchenne Muscular Dystrophy, Becker Muscular Dystrophy, and Related Dystrophinopathies - Developing Potential Treatments for the Entire Spectrum of Disease.
    McDonald C; Camino E; Escandon R; Finkel RS; Fischer R; Flanigan K; Furlong P; Juhasz R; Martin AS; Villa C; Sweeney HL
    J Neuromuscul Dis; 2024; 11(2):499-523. PubMed ID: 38363616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac Management of the Patient With Duchenne Muscular Dystrophy.
    Buddhe S; Cripe L; Friedland-Little J; Kertesz N; Eghtesady P; Finder J; Hor K; Judge DP; Kinnett K; McNally EM; Raman S; Thompson WR; Wagner KR; Olson AK
    Pediatrics; 2018 Oct; 142(Suppl 2):S72-S81. PubMed ID: 30275251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Duchenne muscular dystrophy: an updated review of common available therapies.
    Salmaninejad A; Valilou SF; Bayat H; Ebadi N; Daraei A; Yousefi M; Nesaei A; Mojarrad M
    Int J Neurosci; 2018 Sep; 128(9):854-864. PubMed ID: 29351004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A current approach to heart failure in Duchenne muscular dystrophy.
    D'Amario D; Amodeo A; Adorisio R; Tiziano FD; Leone AM; Perri G; Bruno P; Massetti M; Ferlini A; Pane M; Niccoli G; Porto I; D'Angelo GA; Borovac JA; Mercuri E; Crea F
    Heart; 2017 Nov; 103(22):1770-1779. PubMed ID: 28668906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic Strategies for Duchenne Muscular Dystrophy: An Update.
    Sun C; Shen L; Zhang Z; Xie X
    Genes (Basel); 2020 Jul; 11(8):. PubMed ID: 32717791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Year in review 2019: Neuromuscular diseases.
    Birnkrant DJ; Black JB
    Pediatr Pulmonol; 2020 Oct; 55(10):2542-2546. PubMed ID: 32691988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overview of gene therapy in spinal muscular atrophy and Duchenne muscular dystrophy.
    Abreu NJ; Waldrop MA
    Pediatr Pulmonol; 2021 Apr; 56(4):710-720. PubMed ID: 32886442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurology Care, Diagnostics, and Emerging Therapies of the Patient With Duchenne Muscular Dystrophy.
    Leigh F; Ferlini A; Biggar D; Bushby K; Finkel R; Morgenroth LP; Wagner KR
    Pediatrics; 2018 Oct; 142(Suppl 2):S5-S16. PubMed ID: 30275245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Personalized gene and cell therapy for Duchenne Muscular Dystrophy.
    Barthélémy F; Wein N
    Neuromuscul Disord; 2018 Oct; 28(10):803-824. PubMed ID: 30224293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.